The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...
The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...
Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) ...
The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.
The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the ...
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
All products are independently selected by our editors. If you buy something, we may earn an affiliate commission.
In 2024, the most-read articles published in Population Health, Equity & Outcomes (PHEO) highlighted the promise of ...
Their symptom improvement was likely thanks to their weight loss, the FDA said. Zepbound is a glucagon-like peptide 1 drug that reduces appetite and food intake. The drug's active ingredient, ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback